knowledge -WSS

knowledge

author：entertainment 2025-09-30 22:28:30 - browse：3

Moderna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention.

Basking in the accolades heaped on Moderna’s celebrated Covid-19 vaccine, Afeyan regaled the Boston audience with the company’s origin story and greeted fans who lined up to snap selfies with him. Stuart Cable, a partner in the law firm Goodwin who’s represented Moderna and joined Afeyan on stage, called Moderna “arguably the most successful story in the history of biotechnology.”

But the Cambridge, Mass.-based company can’t afford to rest on its laurels. Two and a half years after its vaccine liberated tens of millions from pandemic lockdowns — ringing up more than $36 billion in sales so far — Moderna faces a changing business and regulatory environment. Demand for Covid shots is waning, a backlash over drug prices is gaining traction, and questions about its next act loom.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： J&J expands global access to TB drug amid advocacy campaign

WSS

Why police arrested suspected Gilgo Beach killer away from his house

Diabetes management: Digital health tools fall short, study says

Biotech investment managers search for lucrative opportunities

Involuntary treatment for addiction doesn't work

Georgia court denies Trump's request to quash DA's 2020 election probe

Georgia court denies Trump's request to quash DA's 2020 election probe

explore

knowledge

focus

Affirmative action in medical school literally saved lives

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

Trump demands the U.S. pay no more for drugs than other countries … again

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

United colonoscopy coverage change 'may cost lives,' doctors say

This gene therapy has record $4.25 million price. It's saved children.

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Global childhood vaccinations edge closer to pre

New air purifier tech could be key to improving indoor air quality

Yancopoulos of Regeneron works to expand Dupixent success

Wikipedia

Bring on the sabbaticals for nurses

Mirador, a new biotech startup, launches with $400 million

Georgia court denies Trump's request to quash DA's 2020 election probe

Michigan AG announces felony charges against 'fake electors' in 2020 election plot

U.K. officials, researchers try to ease path for bespoke genetic treatments

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

focus

hotspot

hotspot

hotspot